Lance H. Wallin
Plus aucun poste en cours
Profil
Lance H.
Wallin served as President & CEO at Data Sciences International, Inc. He was also the Marketing Director-Cardiac Surgery Technologies at Medtronic, Inc. from 1991 to 2002.
He then served as Vice President-Marketing at Urologix, Inc. from 2002 to 2004.
Later, he became the General Manager-DSI Division at Transoma Medical, Inc. Mr. Wallin holds an MBA from the University of Pennsylvania and an undergraduate degree from Carleton College.
Anciens postes connus de Lance H. Wallin
Sociétés | Poste | Fin |
---|---|---|
UROLOGIX, INC. | Sales & Marketing | 01/01/2004 |
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Sales & Marketing | 01/01/2002 |
Data Sciences International, Inc.
Data Sciences International, Inc. BiotechnologyHealth Technology Data Sciences International, Inc. offers telemetry instrumentation and software and services in support of research. Its services include data services, surgical services, validation services and technical training. The firm’s products include implantable and external telemetry, software, signal conditioners, glucose monitoring, infusion pumps and inhalation/exposure systems. The company was founded by Brian P. Brockway in 1984 and is headquartered in St. Paul, MN. | President | - |
Transoma Medical, Inc.
Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Transoma Medical, Inc., headquartered in St. Paul, Minnesota, is a medical technology company engaged in developing, manufacturing and distributing implantable, wireless diagnostic and monitoring systems. Transoma is focused specifically on diagnostic and monitoring technology and dedicated to providing physicians with information needed to accurately and quickly diagnose unexplained, infrequent symptoms and to monitor changing, often asymptomatic complex arrhythmias. Transoma has an extensive technology platform based on more than 20 years experience in developing implantable wireless diagnostic systems for use in biomedical research. These innovative tools have played a key role in drug discovery, pre-clinical evaluation of safety and efficacy, and other academic and government basic research. Customers have turned to DSI for more accurate, timely physiological data, highly humane research practices, and faster times to market. In 2003 the Patient Management division was formed utilizing this proven technology platform and paving the way for the formation of Transoma Medical. | Corporate Officer/Principal | - |
Formation de Lance H. Wallin
University of Pennsylvania | Masters Business Admin |
Carleton College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
UROLOGIX, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Medtronic, Inc.
Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Health Technology |
Transoma Medical, Inc.
Transoma Medical, Inc. Medical/Nursing ServicesHealth Services Transoma Medical, Inc., headquartered in St. Paul, Minnesota, is a medical technology company engaged in developing, manufacturing and distributing implantable, wireless diagnostic and monitoring systems. Transoma is focused specifically on diagnostic and monitoring technology and dedicated to providing physicians with information needed to accurately and quickly diagnose unexplained, infrequent symptoms and to monitor changing, often asymptomatic complex arrhythmias. Transoma has an extensive technology platform based on more than 20 years experience in developing implantable wireless diagnostic systems for use in biomedical research. These innovative tools have played a key role in drug discovery, pre-clinical evaluation of safety and efficacy, and other academic and government basic research. Customers have turned to DSI for more accurate, timely physiological data, highly humane research practices, and faster times to market. In 2003 the Patient Management division was formed utilizing this proven technology platform and paving the way for the formation of Transoma Medical. | Health Services |
Data Sciences International, Inc.
Data Sciences International, Inc. BiotechnologyHealth Technology Data Sciences International, Inc. offers telemetry instrumentation and software and services in support of research. Its services include data services, surgical services, validation services and technical training. The firm’s products include implantable and external telemetry, software, signal conditioners, glucose monitoring, infusion pumps and inhalation/exposure systems. The company was founded by Brian P. Brockway in 1984 and is headquartered in St. Paul, MN. | Health Technology |